Janumet® Tablet is a prescription oral antidiabetic medicine that combines Sitagliptin, a DPP-4 inhibitor, with Metformin, a biguanide, for the management of type 2 diabetes mellitus. This dual-action therapy helps improve glycemic control by enhancing insulin release, reducing glucose production in the liver, and improving insulin sensitivity.

Janumet is commonly prescribed when diet, exercise, or monotherapy does not provide adequate blood sugar control. It is widely trusted by healthcare professionals due to its proven efficacy and balanced safety profile.

Available strengths include 50/500 mg, 50/850 mg, and 50/1000 mg, making it suitable for individualized diabetes treatment plans.

Medicina Overseas supplies Janumet® Tablets for international markets, supporting pharmacies, hospitals, distributors, and bulk importers with reliable sourcing and export-ready documentation.

⚠️ Prescription medicine. Use only under medical supervision.

✅ KEY BENEFITS (OPTIONAL BUT HIGHLY RECOMMENDED)

• Dual-action diabetes control

• Helps maintain stable blood glucose levels

• Reduces risk of hypoglycemia

• Globally recognized combination therapy

• Suitable for long-term diabetes management